Institute of Nano Science and Technology (INST) has been set up at Mohali in Punjab as an autonomous institution focusing on R&D of specific areas in Nano Science and Technology leading to new phenomena, processes, products and devices. INST has started its operations and invites persons with excellent credentials, having innovative mind and an inner urge to deliver, for the following positions:
Sun Pharmaceutical Industries Ltd and includes its subsidiaries or associate companies) announced that one of its wholly owned subsidiaries has received approval from USFDA for its New Drug Application (NDA) related to BromSite™ (bromfenac ophthalmic solution) 0.075% for the treatment of postoperative inflammation and prevention of ocular pain in patients undergoing cataract surgery. BromSite™ is the first non-steroidal anti-inflammatory drug (NSAID) approved by the USFDA to prevent pain and treat inflammation in the eye for patients undergoing cataract surgery; other NSAIDs in this class are currently indicated for the treatment of inflammation and reduction of pain.


